| calcium channel, voltage-dependent, beta 4 subunit |
BENAZEPRIL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
BENAZEPRIL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
BENAZEPRIL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
BENAZEPRIL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
BENAZEPRIL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
BENAZEPRIL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
BENAZEPRIL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
BENAZEPRIL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
BENAZEPRIL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
BENAZEPRIL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 3B |
DEXFENFLURAMINE |
Phosphodiesterase PDE3 |
-16% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 3A |
DEXFENFLURAMINE |
Phosphodiesterase PDE3 |
-16% |
NoneNone |
NoneNone |
View
|
| N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
CROTAMITON |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
CROTAMITON |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
CROTAMITON |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, NMDA2C |
CROTAMITON |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
CROTAMITON |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
CROTAMITON |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
| A3 adenosine receptor |
FLUMAZENIL |
Adenosine A3 |
-16% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 5 (DBSS) |
BENZBROMARONE |
Tumor Necrosis Factor (TNF), Non-Selective |
-16% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 1b |
BENZBROMARONE |
Tumor Necrosis Factor (TNF), Non-Selective |
-16% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 1a |
BENZBROMARONE |
Tumor Necrosis Factor (TNF), Non-Selective |
-16% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 4 |
BENZBROMARONE |
Tumor Necrosis Factor (TNF), Non-Selective |
-16% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) |
BENZBROMARONE |
Tumor Necrosis Factor (TNF), Non-Selective |
-16% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 8 |
BENZBROMARONE |
Tumor Necrosis Factor (TNF), Non-Selective |
-16% |
NoneNone |
NoneNone |
View
|
| FMS-like tyrosine kinase 1 |
FLUMAZENIL |
Vascular Endothelinal Growth Factor (VEGF) |
-16% |
NoneNone |
NoneNone |
View
|
| fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) |
FLUMAZENIL |
Vascular Endothelinal Growth Factor (VEGF) |
-16% |
NoneNone |
NoneNone |
View
|
| neuropeptide Y receptor Y1 |
FLUMAZENIL |
Neuropeptide Y1 |
-16% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
ANISINDIONE |
Calcium Channel Type L, Dihydropyridine |
-16% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
ZOMEPIRAC |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, NMDA2C |
ZOMEPIRAC |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
| matrix metalloproteinase 1 (interstitial collagenase) |
NEOMYCIN |
Protease, Matrix Metalloprotease-1 (MMP-1) |
-16% |
NoneNone |
NoneNone |
View
|
| chemokine (C-C motif) receptor 5 |
ANASTROZOLE |
Chemokine CCR5 |
-16% |
NoneNone |
NoneNone |
View
|
| dopamine receptor D1A |
ANASTROZOLE |
Dopamine D1 |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 |
ZOMEPIRAC |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, gamma 1 |
ZOMEPIRAC |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, pi |
ZOMEPIRAC |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
| AT hook, DNA binding motif, containing 1 (DBSS) |
ZOMEPIRAC |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, theta |
ZOMEPIRAC |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, gamma 2 |
ZOMEPIRAC |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
ZOMEPIRAC |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
| cholecystokinin A receptor |
2-HYDROXYPROPYL-BETA-CYCLODEXTRIN |
Cholecystokinin CCKA |
-16% |
NoneNone |
NoneNone |
View
|
| chemokine (C-C motif) receptor 5 |
2-HYDROXYPROPYL-BETA-CYCLODEXTRIN |
Chemokine CCR5 |
-16% |
NoneNone |
NoneNone |
View
|
| progesterone receptor |
TACROLIMUS |
Progesterone |
-16% |
NoneNone |
NoneNone |
View
|
| progesterone receptor |
TACROLIMUS |
Progesterone |
-16% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 14 |
TACROLIMUS |
Protein Serine/Threonine Kinase, p38alpha |
-16% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 14 |
TACROLIMUS |
Protein Serine/Threonine Kinase, p38alpha |
-16% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2C |
TACROLIMUS |
Serotonin 5-HT2C |
-16% |
NoneNone |
NoneNone |
View
|
| insulin receptor |
TANNIC ACID |
Insulin |
-16% |
NoneNone |
NoneNone |
View
|
| insulin receptor |
TANNIC ACID |
Insulin |
-16% |
NoneNone |
NoneNone |
View
|
| neuropeptide Y receptor Y1 |
AMOBARBITAL |
Neuropeptide Y1 |
-16% |
NoneNone |
NoneNone |
View
|
| aldo-keto reductase family 1, member B4 (aldose reductase) |
U-78517F |
Aldose Reductase |
-16% |
NoneNone |
NoneNone |
View
|
| aldo-keto reductase family 1, member B1 (aldose reductase) |
U-78517F |
Aldose Reductase |
-16% |
NoneNone |
NoneNone |
View
|
| aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) |
U-78517F |
Aldose Reductase |
-16% |
NoneNone |
NoneNone |
View
|
| aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) |
U-78517F |
Aldose Reductase |
-16% |
NoneNone |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
CHLORAMPHENICOL |
Serotonin Transporter |
-16% |
NoneNone |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
IBUPROFEN |
Serotonin Transporter |
-16% |
NoneNone |
NoneNone |
View
|
| chemokine (C-C motif) receptor 5 |
IBUPROFEN |
Chemokine CCR5 |
-16% |
NoneNone |
NoneNone |
View
|
| adenosine A1 receptor |
TANNIC ACID |
Adenosine A1 |
-16% |
NoneNone |
NoneNone |
View
|
| protein kinase C, alpha |
IBUPROFEN |
Protein Serine/Threonine Kinase PKCalpha |
-16% |
NoneNone |
NoneNone |
View
|
| protein kinase C, alpha |
IBUPROFEN |
Protein Serine/Threonine Kinase PKCalpha |
-16% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, muscarinic 4 |
TANNIC ACID |
Muscarinic M4 |
-16% |
NoneNone |
NoneNone |
View
|
| opioid receptor, sigma 1 |
SULINDAC |
Sigma1 |
-16% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 |
CHLOROXYLENOL |
Cyclooxygenase COX-2 |
-16% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
CHLOROXYLENOL |
Cyclooxygenase COX-2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IV, alpha |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type III, alpha |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type II, beta |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type II, alpha 2 |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type I, beta |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type I, alpha |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IV, beta |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel associated protein 1 |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel associated protein 2 |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type III, beta |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type I, alpha |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IX, alpha |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type VII, alpha |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| amiloride-sensitive cation channel 5, intestinal |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type III, beta |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type VIII, alpha polypeptide |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type XI, alpha |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type I, beta |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type 10, alpha polypeptide |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IV, alpha polypeptide |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type V, alpha polypeptide |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type II, beta |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| insulin receptor |
RANITIDINE |
Insulin |
-16% |
NoneNone |
NoneNone |
View
|
| insulin receptor |
RANITIDINE |
Insulin |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IV, beta |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel associated protein 1 |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel associated protein 2 |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type III, beta |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type I, alpha |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IX, alpha |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type VII, alpha |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| amiloride-sensitive cation channel 5, intestinal |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type III, beta |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type VIII, alpha polypeptide |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type XI, alpha |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type I, beta |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| leukotriene C4 synthase |
RANITIDINE |
Leukotriene C4 Synthetase |
-16% |
NoneNone |
NoneNone |
View
|
| leukotriene C4 synthase |
RANITIDINE |
Leukotriene C4 Synthetase |
-16% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2A |
RANITIDINE |
Serotonin 5-HT2A |
-16% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, muscarinic 1 |
CELECOXIB |
Muscarinic M1 |
-16% |
NoneNone |
NoneNone |
View
|
| chemokine (C-C motif) receptor 4 |
ETHANOL |
Chemokine CCR4 |
-16% |
NoneNone |
NoneNone |
View
|
| matrix metallopeptidase 9 |
CELECOXIB |
Protease, Matrix Metalloprotease-9 (MMP-9) |
-16% |
NoneNone |
NoneNone |
View
|
| matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
CELECOXIB |
Protease, Matrix Metalloprotease-9 (MMP-9) |
-16% |
NoneNone |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
CYCLOSPORIN A |
Serotonin Transporter |
-16% |
NoneNone |
NoneNone |
View
|
| cannabinoid receptor 1 (brain) |
NALOXONAZINE |
Cannabinoid CB1 |
-16% |
NoneNone |
NoneNone |
View
|
| synaptic vesicle glycoprotein 2b |
RIFAMPIN |
beta-Lactamase |
-16% |
NoneNone |
NoneNone |
View
|
| chemokine (C-C motif) receptor 5 |
6(5H)-PHENANTHRIDINONE |
Chemokine CCR5 |
-16% |
NoneNone |
NoneNone |
View
|
| nitric oxide synthase 3 (endothelial cell) |
AMINOCAPROIC ACID |
Nitric Oxide Synthase, Constitutive (cNOS) |
-16% |
NoneNone |
NoneNone |
View
|
| nitric oxide synthase 3, endothelial cell |
AMINOCAPROIC ACID |
Nitric Oxide Synthase, Constitutive (cNOS) |
-16% |
NoneNone |
NoneNone |
View
|
| 3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
ETOPOSIDE |
HMG-CoA Reductase |
-16% |
NoneNone |
NoneNone |
View
|
| 3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
ETOPOSIDE |
HMG-CoA Reductase |
-16% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor |
PREDNISOLONE |
Leukotriene B4 |
-16% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor |
PREDNISOLONE |
Leukotriene B4 |
-16% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor 2 |
PREDNISOLONE |
Leukotriene B4 |
-16% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1B |
SIMVASTATIN |
Serotonin 5-HT1B |
-16% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1A |
MEVASTATIN |
Serotonin 5-HT1A |
-16% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2a |
MEVASTATIN |
Imidazoline I2, Central |
-16% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
MEVASTATIN |
Imidazoline I2, Central |
-16% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 1 |
SULCONAZOLE |
Protein Serine/Threonine Kinase, ERK2 |
-16% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 1 |
SULCONAZOLE |
Protein Serine/Threonine Kinase, ERK2 |
-16% |
NoneNone |
NoneNone |
View
|
| endothelin receptor type A |
LY-294002 |
Endothelin ETA |
-16% |
NoneNone |
NoneNone |
View
|
| Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
CEFOTAXIME |
CYP450-2C9 Inhibition |
-16% |
NoneNone |
NoneNone |
View
|
| cytochrome P450, family 2, subfamily C, polypeptide 9 |
CEFOTAXIME |
CYP450-2C9 Inhibition |
-16% |
NoneNone |
NoneNone |
View
|
| neuropeptide Y receptor Y1 |
MEDROXYPROGESTERONE |
Neuropeptide Y1 |
-16% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-1A2 monooxygenase |
ANTIPYRINE |
CYP450-1A2 Inhibition |
-16% |
NoneNone |
NoneNone |
View
|
| interleukin 8 receptor, beta |
DIMETHYL SULFOXIDE |
Chemokine CXCR2 (IL-8B) |
-16% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-1A2 monooxygenase |
DEFERIPRONE |
CYP450-1A2 Inhibition |
-16% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 1a |
DIMETHYL SULFOXIDE |
Adrenergic alpha1A |
-16% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, muscarinic 5 |
FLUTAMIDE |
Muscarinic M5 |
-16% |
NoneNone |
NoneNone |
View
|
| leukotriene C4 synthase |
AZAURIDINE |
Leukotriene C4 Synthetase |
-16% |
NoneNone |
NoneNone |
View
|
| leukotriene C4 synthase |
AZAURIDINE |
Leukotriene C4 Synthetase |
-16% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 14 |
ENALAPRIL |
Protein Serine/Threonine Kinase, p38alpha |
-16% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 14 |
ENALAPRIL |
Protein Serine/Threonine Kinase, p38alpha |
-16% |
NoneNone |
NoneNone |
View
|
| leukotriene C4 synthase |
ESTRONE |
Leukotriene C4 Synthetase |
-16% |
NoneNone |
NoneNone |
View
|
| leukotriene C4 synthase |
ESTRONE |
Leukotriene C4 Synthetase |
-16% |
NoneNone |
NoneNone |
View
|
| opioid receptor, kappa 1 |
METOPROLOL |
Opiate kappa |
-16% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 5 (DBSS) |
LIPOPOLYSACCHARIDE E. COLI O55:B5 |
Tumor Necrosis Factor (TNF), Non-Selective |
-16% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 1b |
LIPOPOLYSACCHARIDE E. COLI O55:B5 |
Tumor Necrosis Factor (TNF), Non-Selective |
-16% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 1a |
LIPOPOLYSACCHARIDE E. COLI O55:B5 |
Tumor Necrosis Factor (TNF), Non-Selective |
-16% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 4 |
LIPOPOLYSACCHARIDE E. COLI O55:B5 |
Tumor Necrosis Factor (TNF), Non-Selective |
-16% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) |
LIPOPOLYSACCHARIDE E. COLI O55:B5 |
Tumor Necrosis Factor (TNF), Non-Selective |
-16% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 4 |
MITOTANE |
Tumor Necrosis Factor (TNF), Non-Selective |
-16% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) |
MITOTANE |
Tumor Necrosis Factor (TNF), Non-Selective |
-16% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 8 |
MITOTANE |
Tumor Necrosis Factor (TNF), Non-Selective |
-16% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor 2 |
DIELDRIN |
Leukotriene B4 |
-16% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor |
DIELDRIN |
Leukotriene B4 |
-16% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor |
DIELDRIN |
Leukotriene B4 |
-16% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor 2 |
DIELDRIN |
Leukotriene B4 |
-16% |
NoneNone |
NoneNone |
View
|
| calcitonin receptor |
SULFADIMETHOXINE |
Calcitonin |
-16% |
NoneNone |
NoneNone |
View
|
| arginine vasopressin receptor 1A |
N,N'-DIPHENYL-P-PHENYLENEDIAMINE |
Vasopressin V1A |
-16% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, muscarinic 1 |
TIAPRIDE |
Muscarinic M1 |
-16% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor 2 |
PROPYLTHIOURACIL |
Leukotriene B4 |
-16% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor |
PROPYLTHIOURACIL |
Leukotriene B4 |
-16% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor |
PROPYLTHIOURACIL |
Leukotriene B4 |
-16% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor 2 |
PROPYLTHIOURACIL |
Leukotriene B4 |
-16% |
NoneNone |
NoneNone |
View
|
| interleukin 8 receptor, beta |
HYDRAZINE |
Chemokine CXCR2 (IL-8B) |
-16% |
NoneNone |
NoneNone |
View
|
| nuclear receptor subfamily 3, group C, member 1 |
PROPYLTHIOURACIL |
Glucocorticoid |
-16% |
NoneNone |
NoneNone |
View
|
| melanocortin 4 receptor |
PROPYLTHIOURACIL |
Melanocortin MC4 |
-16% |
NoneNone |
NoneNone |
View
|
| cannabinoid receptor 1 (brain) |
RISEDRONIC ACID |
Cannabinoid CB1 |
-16% |
NoneNone |
NoneNone |
View
|
| progesterone receptor |
LEVOFLOXACIN |
Progesterone |
-16% |
NoneNone |
NoneNone |
View
|
| progesterone receptor |
LEVOFLOXACIN |
Progesterone |
-16% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 3 |
DOXIFLURIDINE |
Protein Serine/Threonine Kinase, ERK1 |
-16% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 3 |
DOXIFLURIDINE |
Protein Serine/Threonine Kinase, ERK1 |
-16% |
NoneNone |
NoneNone |
View
|
| DNA encoding receptor of vasoactive intestinal polypeptide |
PROPRANOLOL |
Vasoactive Intestinal Peptide VIP1 |
-16% |
NoneNone |
NoneNone |
View
|
| androgen receptor |
LEVOCARNITINE |
Testosterone |
-16% |
NoneNone |
NoneNone |
View
|
| DNA encoding receptor of vasoactive intestinal polypeptide |
LEVODOPA |
Vasoactive Intestinal Peptide VIP1 |
-16% |
NoneNone |
NoneNone |
View
|
| dopamine receptor 2 |
ARTEMETHER |
Dopamine D2L |
-16% |
NoneNone |
NoneNone |
View
|
| caspase 1 |
QUINACRINE |
Protease, Caspase 1 |
-16% |
NoneNone |
NoneNone |
View
|
| caspase 1, apoptosis-related cysteine protease (interleukin 1, beta, convertase) |
QUINACRINE |
Protease, Caspase 1 |
-16% |
NoneNone |
NoneNone |
View
|
| caspase 3, apoptosis related cysteine protease |
QUINACRINE |
Protease, Caspase 1 |
-16% |
NoneNone |
NoneNone |
View
|
| caspase 2 |
QUINACRINE |
Protease, Caspase 1 |
-16% |
NoneNone |
NoneNone |
View
|
| caspase 7 |
QUINACRINE |
Protease, Caspase 1 |
-16% |
NoneNone |
NoneNone |
View
|
| caspase 6 |
QUINACRINE |
Protease, Caspase 1 |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 |
PYRAZINAMIDE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, gamma 1 |
PYRAZINAMIDE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, pi |
PYRAZINAMIDE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
| AT hook, DNA binding motif, containing 1 (DBSS) |
PYRAZINAMIDE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, theta |
PYRAZINAMIDE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, gamma 2 |
PYRAZINAMIDE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
PYRAZINAMIDE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
PYRAZINAMIDE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, alpha 2 |
PYRAZINAMIDE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, alpha 1 |
PYRAZINAMIDE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
PYRAZINAMIDE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
PYRAZINAMIDE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, delta |
PYRAZINAMIDE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
PYRAZINAMIDE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
| dopamine receptor D4 |
RISEDRONIC ACID |
Dopamine D4.2 |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, gamma 1 |
FLEROXACIN |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, pi |
FLEROXACIN |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
| AT hook, DNA binding motif, containing 1 (DBSS) |
FLEROXACIN |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, theta |
FLEROXACIN |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, gamma 2 |
FLEROXACIN |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
FLEROXACIN |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
FLEROXACIN |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|